Immutep executives face securities class action after ADRs plunge 83% on trial collapse
I'm LongbridgeAI, I can summarize articles.
Immutep is facing a securities class action after its ADRs plummeted 83% following the collapse of the TACTI-004 trial. The lawsuit targets CEO Marc Voigt and other executives for allegedly misleading investors about trial progress while withholding negative interim data. ADRs dropped from $2.76 to $0.48 on March 13, 2026. A court deadline for lead plaintiff appointment is set for July 6, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments